N/A N=100 Randomized Triple-blind Treatment

Low Level Laser Therapy to Reduce Chronic Pain

Chronic Pain

Bottom Line

View on ClinicalTrials.gov: NCT00929773 ↗

Enrolled (actual)

100

Serious AEs

0.0%

Results posted

May 2014

Primary outcome: Primary: Number of Participants Whose Self-reported Degree of Pain on the Visual Analog Scale (VAS) in the Neck and Shoulder Area Decreased by 30% or More From Before to After Study Treatment. — 40; 7 participants — p=<0.0001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Erchonia PL2000 Laser (Device); Placebo laser (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Erchonia Corporation
Primary completion: Sep 2000

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Whose Self-reported Degree of Pain on the Visual Analog Scale (VAS) in the Neck and Shoulder Area Decreased by 30% or More From Before to After Study Treatment.	40; 7	<0.0001 sig
PRIMARY Change in Self-reported Degree of Pain in the Neck-shoulder Region on the 0-100 Visual Analog Scale (VAS)	-27.38; -2.43	<0.0001 sig
SECONDARY Change in Range of Motion (ROM) for the Left Side of the Neck From Baseline to One Hour After Study Treatment.	11.28; 0.02	<.0001 sig
SECONDARY Change in Range of Motion (ROM) for the Left Shoulder From Baseline to One Hour After Study Treatment.	28.00; 2.24	<0.0001 sig
SECONDARY Change in Range of Motion (ROM) for the Right Side of the Neck From Baseline to One Hour After Study Treatment.	11.06; 0.72	<0.0001 sig
SECONDARY Change in Range of Motion (ROM) for the Right Shoulder From Baseline to One Hour After Study Treatment.	30.90; 1.70	<0.0001 sig

Summary

The purpose of this study was to determine whether low level laser light directed at the neck and shoulders could be effective in the temporary reduction of chronic pain in the neck and shoulder region.

Eligibility Criteria

Inclusion Criteria

Muscular-skeletal pain in the neck/shoulder region
Acute and chronic pain in the neck/shoulder region
Restricted range of motion in the neck/shoulder region
Fibrosis or scar tissue in the neck/shoulder region
Inflammation in the neck/shoulder region
Altered function in the neck/shoulder region
Muscle strains in the neck/shoulder region
Rating of 30 or greater on the 0-100 Visual Analog Scale (VAS) pain scale
18-65 years of age

Exclusion Criteria

Severely herniated disks
Pregnancy
Taken pain medication within the past 12 hours

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00929773). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.